Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22517548 | 0.89 | ALDH1A1 (0.37) | PDK2ALDH1A1MAPTCDC25BHDAC8 | |
| SCHEMBL29892218 | 0.85 | PDK2 (0.39) | PDK2MAPT | |
| SCHEMBL15713467 | 0.85 | PDK2 (0.39) | PDK2MAPT | |
| SCHEMBL22517374 | 0.84 | ALDH1A1 (0.37) | PDK2ALDH1A1MAPTCDC25B | |
| SCHEMBL22517274 | 0.84 | ALDH1A1 (0.36) | PDK2ALDH1A1MAPT | |
| SCHEMBL17454691 | 0.84 | PDK2 (0.41) | PDK2MAPT | |
| SCHEMBL23137801 | 0.83 | ALDH1A1 (0.37) | PDK2ALDH1A1MAPTCDC25B | |
| SCHEMBL17760145 | 0.82 | CDC25B (0.41) | PDK2ALDH1A1MAPTCDC25B | |
| SCHEMBL17759523 | 0.82 | ALDH1A1 (0.38) | PDK2ALDH1A1MAPT | |
| SCHEMBL19153545 | 0.81 | HDAC4 (0.41) | PDK2MAPTHDAC4HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025872-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, CYP1A1 | PDK2 2186/4885ALDH1A1 8/4885MAPT 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.